Cubist Systematic Strategies’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $8.21M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.92M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $141K | Sell |
|
|||||
|
2022
Q4 | $11.8M | Buy |
|
|||||
|
2022
Q3 | $4.66M | Buy |
|
|||||
|
2022
Q2 | $2.57M | Buy |
|
|||||
|
2022
Q1 | $858K | Sell |
|
|||||
|
2021
Q4 | $3.31M | Buy |
|
|||||
|
2021
Q3 | $1.35M | Sell |
|
|||||
|
2021
Q2 | $4.29M | Buy |
|
|||||
|
2021
Q1 | $4.97M | Buy |
|
|||||
|
2020
Q4 | $629K | Sell |
|
|||||
|
2020
Q3 | $1.34M | Sell |
|
|||||
|
2020
Q2 | $15.9M | Buy |
|
|||||
|
2020
Q1 | $170K | Sell |
|
|||||
|
2019
Q4 | $2.89M | Buy |
|
|||||
|
2019
Q3 | $1.14M | Buy |
|
|||||
|
2019
Q2 | $7K | Sell |
|
|||||
|
2019
Q1 | $773K | Buy |
|
|||||
|
2018
Q4 | $120K | Sell |
|
|||||
|
2018
Q3 | $341K | Sell |
|
|||||
|
2018
Q2 | $2.56M | Buy |
|
|||||
|
2018
Q1 | $181K | Sell |
|
|||||
|
2017
Q4 | $520K | Buy |
|
|||||
|
2017
Q3 | $389K | Buy |
|
|||||
|
2017
Q2 | $260K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $410K | Buy |
|
|||||
|
2016
Q3 | $178K | Sell |
|
|||||
|
2016
Q2 | $650K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $291K | Buy |
|
|||||
|
2015
Q2 | $282K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $288K | Buy |
|
|||||
|
2014
Q3 | $255K | Sell |
|
|||||
|
2014
Q2 | $335K | Buy |
|